The global electronic trial master file systems market size was estimated at USD 0.75 billion in 2023 and it is expected to surpass around USD 2.97 billion by 2033, poised to grow at a CAGR of 14.75% from 2024 to 2033.
Electronic Trial Master File Systems Market Overview
The Electronic Trial Master File (eTMF) systems market has witnessed significant growth in recent years due to the increasing adoption of electronic document management solutions in the pharmaceutical and biotechnology industries. eTMF systems play a crucial role in streamlining clinical trial processes, enhancing regulatory compliance, and improving collaboration among stakeholders.
Electronic Trial Master File Systems Market Growth
Delivery Mode Insights
The cloud and web-based segment dominated the market, holding the largest revenue share of 92% in 2023. This was due to its various benefits, including easy accessibility, usability, and lower investments. Cloud and web-based products also offer easy customization options, allowing providers to effectively tailor information presentations for different user groups. Additionally, these products demonstrate higher interoperability, further enhancing their appeal. It is expected that this segment will continue to maintain its leading position throughout the forecast period.
Conversely, the on-premise delivery mode involves installing services and solutions on computers within the organization. Despite requiring on-site installation, it can still be accessed from remote locations, offering the advantage of reduced costs associated with power consumption and system maintenance. The on-premise eTMF solution is highly preferred due to its benefits, such as enhanced security and ease of access. The preference for these services primarily arises from the complete access to information and the sense of full control maintained within the organization’s premises
Clinical Trials Insights
End-use Insights
In 2023, the Contract Research Organizations (CROs) segment emerged as the market leader, capturing the largest revenue share of 38%. Furthermore, this segment is projected to experience the highest Compound Annual Growth Rate (CAGR) of 15.05% during the forecast period. A key driver behind this growth is the increasing emphasis among pharmaceutical companies on reducing overall expenditure, leading to a surge in the adoption of eTMF (Electronic Trial Master File) solutions within research operations.
The notable benefits associated with outsourcing clinical trials to CROs have significantly fueled the expansion of this segment. For instance, in January 2021, ICON plc provided clinical trial services to BioNTech SE and Pfizer, showcasing the advantages of strong partnerships between sponsors and CROs. This collaborative effort has set new industry standards in terms of trial management efficiency and speed, highlighting the transformative impact of such alliances.
Regional Insights
Electronic Trial Master File Systems Market Key Companies
- Oracle
- Clinevo Technologies
- MasterControl Solutions, Inc.
- Veeva Systems
- Aris Global LLC
- PHARMALEX GMBH
- TransPerfect
- Aurea, Inc.
- ePharmaSolutions (WCG Clinical)
- SureClinical Inc.
- Ennov
- Montrium Inc.
- Cloudbyz
- TRIAL INTERACTIVE
- Anju Software
- Octalsoft
- Egnyte, Inc.
Electronic Trial Master File Systems Market Segmentations:
By Delivery Mode
- Cloud And Web-based
- On-premise
By Clinical Trials
- Phase I
- Phase II
- Phase III
- Phase IV
By End-use
- Hospitals/Healthcare providers
- Contract Research Organizations (CROs)
- Academic Institutes
- Pharma & Biotech Organizations
- Medical Device Manufacturers
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/41170
You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308